(Q37800007)

23 August 2017

title

Enrichment of clinical study populations (English)

1 reference

23 August 2017

Enrichment of Clinical Study Populations (English)

1 reference

DOI

10.1038/CLPT.2010.233

https://api.crossref.org/works/10.1038/CLPT.2010.233

1 August 2024

author name string

R. Temple

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20944560

1 August 2024

language of work or name

English

0 references

publication date

13 October 2010

1 reference

Clinical Pharmacology & Therapeutics

23 August 2017

published in

1 reference

23 August 2017

volume

88

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

774-778

1 reference

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

Concordance among gene-expression-based predictors for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

A Clinical Trial Design Avoiding Undue Placebo Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

inferred from DOI database lookup

7 January 2021

based on heuristic

Total suppression of ventricular arrhythmias by encainide. Pharmacokinetic and electrocardiographic characteristics

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.233

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2010.233

1 reference

release_wrr67dzsdbck3ensh7kikmsdh4

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wrr67dzsdbck3ensh7kikmsdh4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference